Studies by Ahmed et al. [90] demonstrated a significant loss of IPMK in the striatal brain samples of both humans and mice with Huntington’s disease (HD), suggesting IPMK’s involvement in the pathogenesis of this neurodegenerative disorder. The gene discussed is IPMK; the disease is juvenile Huntington disease.